1. Home
  2. NRXP vs WAVE Comparison

NRXP vs WAVE Comparison

Compare NRXP & WAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • WAVE
  • Stock Information
  • Founded
  • NRXP 2015
  • WAVE 2011
  • Country
  • NRXP United States
  • WAVE Israel
  • Employees
  • NRXP N/A
  • WAVE N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • WAVE Electric Utilities: Central
  • Sector
  • NRXP Health Care
  • WAVE Utilities
  • Exchange
  • NRXP Nasdaq
  • WAVE Nasdaq
  • Market Cap
  • NRXP 32.6M
  • WAVE 27.0M
  • IPO Year
  • NRXP N/A
  • WAVE 2021
  • Fundamental
  • Price
  • NRXP $3.01
  • WAVE $6.63
  • Analyst Decision
  • NRXP Strong Buy
  • WAVE Strong Buy
  • Analyst Count
  • NRXP 4
  • WAVE 1
  • Target Price
  • NRXP $28.50
  • WAVE $15.00
  • AVG Volume (30 Days)
  • NRXP 190.3K
  • WAVE 20.2K
  • Earning Date
  • NRXP 08-13-2025
  • WAVE 08-28-2025
  • Dividend Yield
  • NRXP N/A
  • WAVE N/A
  • EPS Growth
  • NRXP N/A
  • WAVE N/A
  • EPS
  • NRXP N/A
  • WAVE N/A
  • Revenue
  • NRXP N/A
  • WAVE $168,000.00
  • Revenue This Year
  • NRXP N/A
  • WAVE $325.00
  • Revenue Next Year
  • NRXP N/A
  • WAVE $85.71
  • P/E Ratio
  • NRXP N/A
  • WAVE N/A
  • Revenue Growth
  • NRXP N/A
  • WAVE N/A
  • 52 Week Low
  • NRXP $1.10
  • WAVE $2.39
  • 52 Week High
  • NRXP $6.01
  • WAVE $17.63
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 42.90
  • WAVE 53.83
  • Support Level
  • NRXP $3.12
  • WAVE $6.02
  • Resistance Level
  • NRXP $3.53
  • WAVE $6.79
  • Average True Range (ATR)
  • NRXP 0.18
  • WAVE 0.37
  • MACD
  • NRXP -0.06
  • WAVE 0.01
  • Stochastic Oscillator
  • NRXP 1.89
  • WAVE 60.76

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

Share on Social Networks: